almotriptan
Sign in to saveAlso known as Axert®, LAS-31416, PNU-180638E, 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine
Almotriptan, sold under the brand names Axert and Almogran among others, is a triptan medication used in the treatment of heavy migraine headache.
Research
311 papers- Almotriptan.2006
- Almotriptan: a review of 20 years' clinical experience.Expert review of neurotherapeutics · 2019
- Almotriptan.2026
- Almotriptan: a review of its use in migraine.Drugs · 2002
- Almotriptan, a new anti-migraine agent: a review.CNS drug reviews · 2002
via PubMed
~5 min read
Encyclopedic overview
14 sectionsContents
- Medical uses
- Effectiveness
- Contraindications
- Side effects
- Interactions
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Chemistry
- History
- Society and culture
- Brand names
- References
- External links
Almotriptan, sold under the brand names Axert and Almogran among others, is a triptan medication used in the treatment of heavy migraine headache.
Almotriptan was patented in 1992 and approved for medical use in 2000. It was discovered and developed by Almirall-Prodesfarma.
Excerpted from Wikipedia’s “almotriptan” article, available under the CC BY-SA 4.0 licence.